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1. Introduction 
Ataxia telangiectasia like disorder (ATLD) is a rare variant of ataxia telangiectasia (A-T) that 
share a number of clinical features and similar cellular characteristics with the hallmark of 
increased sensitivity to ionizing radiation (Taylor et al., 1975; Taylor, 2001; Tauchi et al., 
2002). These conditions are typically diagnosed at young age at about the time the affected 
children start to walk. A-T and ATLD patients develop progressive cerebellar ataxia which 
is required for their clinical diagnosis. Although classified as another variant of A-T, 
Nijmegen breakage syndrome (NBS) is characterized by microcephaly and growth 
retardation without ataxia. The other major clinical characteristics are variable and include 
dilated blood vessels (telangiectasia) usually in the eyes, immunodeficiency, high level of 
spontaneously occurring chromosome abnormalities, and predisposition to cancer 
particularly lymphoreticular malignancies. Genetically, the A-T is caused by biallelic 
inactivating mutations in the ATM gene at 11q22-23, the NBS is caused by mutation in the 
NBS1 gene mapped at 8q21, and the ATLD is caused by mutation in the MRE11A gene 
located at 11q21.  
Therefore, a disorder virtually indistinguishable from A-T is caused by mutation in the 
MRE11A gene. In view of the fact that the ATM and the MRE11A loci are situated nearby 
(11q22-23 and 11q21) only a very detailed linkage analysis would have historically 
separated ATLD from A-T on the basis of genetic data. Assuming that the mutation rate is 
proportional to the length of the coding sequence of the two genes, about 6% of A-T cases 
might be expected to have MRE11A mutations (Stewart et al., 1999). Thus, ATLD patients 
were first recognized as a subset of A-T who does not have mutations in the ATM gene. 
Hence, Stewart et al. had designated this syndrome as ataxia-telagnietasia-like disorder 
(Stewart et al., 1999). The clinical features are very similar to those of A-T; with the clearest 
similarity being the progressive cerebellar ataxia. In contrast to A-T, however, ATLD 
patients show no telangiectasia (Hernandez et al., 1993;  Klein et al., 1996). In addition, the 
patients show later onset of the neurological features, and slower progression of the 
disorder giving the overall appearance of a milder A-T condition in early years.  
The function of Mre11 protein is linked to Nbs1 and both are members of the 
Mre11/Rad50/Nbs1 (MRN) complex involved in different DNA healing mechanisms due to 
innate processes or in responses to damage induced by ionizing radiation and radiomimetic 
chemicals (Carney et al., 1998;  Petrini, 2000), including complexing with chromatin and 
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with other damage response proteins, formation of radiation-induced foci, and the 
induction of cell cycle checkpoints (Figure 1). The MRN complex is among the earliest 
respondents to DNA damage and acts as sensor of DNA double-strand breaks (DSBs). Upon 
exposure to ionizing radiation the complex along with ATM becomes rapidly activated and 
associate with the DNA DSBs (Figure 2). This association holds broken DNA ends until the 
damage is repaired (Nelms et al., 1998). Loss of functional Nbs1 protein in NBS patients 
prevents the formation of the radiation-induced Mre11/Rad50 nuclear foci (Carney et al., 
1998). In comparison, the loss of function of ATM protein in A-T patients causes abnormal 
reduction in the formation of MRN foci that is less severe than in NBS cells (Maser et al., 
1997). Thus, the function of MRN proteins complex is biochemically linked to ATM, which 
is a critical component of the cellular response to DNA damage. Since Nbs1 and ATM 
deficiencies abrogate specific DNA damage-dependent cell cycle checkpoints, the 
association of MRN complex with DSBs suggests that the DNA damage recognition 
functions of the complex are linked to the signal transduction pathways required to activate 
ATM-dependent cell cycle checkpoints. These observations strengthen the molecular 
connection between DSB recognition by MRN protein complex and the ability of the cell to 
activate the DNA damage response pathway controlled by ATM.  
2. Clinical manifestations of ATLD 
ATLD is rare with, at present, only 25 published cases, four in the UK (2 of them from 
Pakistani origin), two in Italy, 15 in Saudi Arabia and four in Japan (Stewart et al., 1999;  
Pitts et al., 2001;  A.M. Taylor et al., 2004;  Fernet et al., 2005;  Uchisaka et al., 2009;  Bohlega 
et al., 2011;  Matsumoto et al., 2011).  The 4 British patients belonged to 2 unrelated families. 
Although none of the affected individuals from either family exhibited ocular telangiectasia, 
they presented with many clinical features consistent with the diagnosis of A-T, especially 
progressive cerebellar degeneration (Stewart et al., 1999). The 2 affected Italian patients were 
born to non-consanguineous parents. They had both normal psychomotor development 
until the age of 3 - 6 years when they developed progressive unsteadiness, showed diffuse 
cerebellar signs, i.e. ataxic gait, delayed speech and writing difficulties, choreoathetoid arm 
movements and oculomotor apraxia (Delia et al., 2004). The disease progressed slowly till 
the age of 14 and then stabilized. The latest neurological examination of the elder patient at 
36 years of age showed cerebellar dysarthria, oculomotor apraxia, ataxic gait with unaided 
walk for few steps, choreoathethosis of the superior limbs, jerk nystagmus on horizontal and 
vertical gaze, dysmetria, dyskinetic movements of mouth and slight dystonia of the hands, 
diffuse hypotonia, reduced tendon reflexes in the arms, and absent ankle jerks with flexor 
plantar responses.  
The 15 Saudi patients represent the largest set of ATLDs identified to date. Consanguinity is 
a major feature in all these families with affected children with parents were mostly first 
cousins. Patients were initially presented with clinical features that fall within the Ataxia 
Oculomotor Apraxia spectrum and exhibited a combination of early-onset, slowly 
progressive, ataxia plus ocular apraxia. Age at onset is almost similar to that of AT, but 
disease progression is slower with the absence of telangiectasia. Pedigrees and further 
details on these families were described previously (Fernet et al., 2005;  Bohlega et al., 2011). 
Clinical features include progressive ataxia that was noted as early as two years old in some 
patients. Oculomotor apraxia was variable among the affected individuals with very slow 
saccadic eye movement and impaired vertical and or horizontal pursuit eye movement with  
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Fig. 1. Role of the Mre11 protein in the cellular response and DNA repair machinery 
showing the major interacting molecules (Adapted from: www.lmb.uni-
muenchen.de/hopfner/research.html with modification). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Representation of the ATM and the Mre11/Rad50/Nbs1 (MRN) complex interacting 
with a DNA double strand break (DSB). The Mre11 exonuclease directly binds Nbs1, Rad50 
and DNA to bridge DSBs and facilitate DNA end processing. The C-terminal of the ataxia 
telangiectasia mutated (ATM) kinase contributing to MRN regulatory roles in DSB sensing, 
stabilization, signaling, and effector scaffolding. MRN has 3 coupled critical functions: (1) 
prompt establishment of protein--nucleic acid tethering scaffolds for the recognition and 
stabilization of DSBs; (2) initiation of DSB sensing, cell-cycle checkpoint signaling cascades 
via the ATM kinase; and (3) functional regulation of chromatin remodeling in the vicinity of 
a DSB (Williams et al., 2007). 
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head thrusts. Vibration senses were decreased distally and tendon reflexes were absent. 
Although few patients had no cognitive impairment, others presented cognitive and 
behavioral problem with forgetfulness, lack of attention, word finding difficulty, emotional 
liability, impulsivity and disinhibition with fragmented and reversed sleep patterns. 
Dysarthria in addition to dystonic and choreatic movement were frequently noted. The 
disease was relentlessly progressive and some patients became wheelchair-bound around 
age of 18 years. Intra-familial variability was noticeable with some patients were more 
severely affected. The clinical observations on this set of patients, together with those from 
previously reported cases, establish that ATLD is not associated with recurrent pulmonary 
infections due to immune deficiency. However, some patients presented with certain 
differences with the previously reported ATLD patients, namely the presence of 
microcephaly in at least four patients, the latter feature being reminiscent of the clinical 
presentation of NBS. Whether these differences are specific to the W210C mutation found in 
Saudi patients or only reflect the wide spectrum of the disease needs further investigation. 
The 4 Japanese patients were born to non-consanguineous parents. Two sibling patients 
were born after healthy pregnancies and deliveries. They had characteristic clinical features 
of short stature, pointy nose, small jaw, atrophy of the lower legs, and equinus foot 
deformities (Uchisaka et al., 2009). They had cerebellar ataxia, slurred and explosive speech, 
and ocular apraxia, but did not show any evidence of involuntary movement such as 
dystonia or dyskinesia. The patients started to speak at 2 years old where ataxic gait was 
noted. The cerebellar ataxia with atrophy of the cerebellum and mental retardation had 
progressed and was more severe in the elder patient who became wheelchair bound at 6 
years of age. There was no history of serious infection or evidence of skin or conjunctival 
telangiectasia. When they were 15 and 9 years old, both patients were diagnosed with 
nonsmall-cell lung cancer with multiple bone metastases. One Japanese patient was born at 
37 weeks of gestation after unremarkable pregnancy. However, the patient showed 
developmental retardation where he could sit alone but could not stand or walk 
(Matsumoto et al., 2011). At age 13 years, the patient had severe microcephaly, a bird-like 
face with sloping forehead, a big nose, large and simple ears, short palpebral fissures, a 
small mouth, and a small and receding chin with decreased range of motion in shoulders, 
elbows, hips, and knees. Also noted were scoliosis, subluxation of the left elbow joint, 
bilateral cryptorchidism, and bilateral talipes equinus. His tendon reflexes were slightly 
exaggerated. At age 33, the patient does not speak meaningful words, but recognizes people, 
communicates by gesture, shows fondness by touching, does not show ocular apraxia and 
had neither malignancy nor severe infections. The 4th Japanese patient had intrauterine 
growth retardation with a small femora and a disproportionately small head (Matsumoto et 
al., 2011). After caesarian section delivery the patient had severe microcephaly, a bird-
headed facial appearance with receding forehead, and a prominent nose. Anterior fontanel 
was not palpable. He stood holding onto a chair at age 30 months, sat alone and walked at 
age 3 years. He had no severe or recurrent infections. Now aged 8 years, he is toilet trained, 
speaks several meaningful words but sentence. He attends a primary school, and is affable 
and friendly. He is farsighted with astigmatism. He is able to run with a slow pitch and kick 
a soccer ball. He shows neither ocular apraxia nor cerebellar ataxia.  
3. MRE11A gene mutations 
The 25 genetically confirmed ATLD patients (4 in the UK, 2 in Italy, 4 in Japan and 15 in 
Saudi Arabia were either homozygous or compound heterozygous for 10 different 
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mutations (Figure 3).  The four British patients were related to two independent families. 
The two patients of the 1st family were homozygous for a C-to-T transition at nucleotide 
1897 (c.1897C>T). This change, CGA>TGA, resulted in an in frame 633R > stop codon, 
prematurely truncating the Mre11 protein. The two patients of the 2nd family were 
compound heterozygous for two mutations, an A>G missense mutation at nucleotide 350 
(c.350A>G), resulting in a Asn to Ser amino acid change at residue 117 (N117S) and C-to-T 
transition at nucleotide 1714 (c.1714C>T) resulting in a stop codon (572R> stop) (A.M. 
Taylor et al., 2004). This mutation is predicted to encode a prematurely truncated protein of 
65 kDa that was not detected suggesting that this mutation destabilizes the transcript by 
nonsense-mediated decay (NMD) surveillance mechanism which eliminates the errors in the 
biogensis of mRNA (Frischmeyer et al., 2002;  Nicholson et al., 2010). The two Italian sibling 
patients were compound heterozygous for two mutations, a missense mutation at position 
1422 (c.1422C>A) resulting in Thr to Lys amino acid change at residue 481 (T481K) and the 
already known single C>T base change in exon 15, corresponding to nucleotide 1714 in the 
cDNA sequence (c.1714C>T), which introduces a premature stop codon (Delia et al., 2004).  
The four Japanese patients belonged to 3 unrelated families. In two brothers with ATLD 
with lung cancer, genetic studies had looked at alteration in the 20 exons and the flanking 
intronic sequences of the MRE11A gene. This revealed a T>C substitution in exon 8 at 
position 727 (c.727T>C) and a G>C base substitution at nucleotide 24994 situated in intron 
10 (g.24994G>A; Figure 3), 5bp downstream from exon 10 (Uchisaka et al., 2009). RT-PCR 
showed the presence of two products. Sequencing of these cDNA products confirmed the 
T>C base substitution at nucleotide 727 in exon 8 in 1 of the alleles and uncovered an 81 bp 
deletion in exon 10 on another allele. The alteration of these DNA sequences predicted a Trp 
to Arg amino acid substitution at residue 243 (W243R) and the loss of 27 amino acids, 
respectively. The base substitution in intron 10 might have given rise to an alternative 
splicing of MRE11A, leading to an in frame 81 bp deletion in exon 10. Thus, the two 
Japanese sibling patients were compound heterozygous for two novel MRE11A gene 
mutations that have not been reported before, one in exon 8 (c.727 T>C) and one in intron 10 
(g.24994 G>A).  
The two other unrelated Japanese patients were presented with NBS-like severe 
microcephaly, bird-like faces, growth and mental retardation remnant of Nijmegen breakage 
syndrome (NBS). However, genetic studies revealed no mutation in the NBN gene 
responsible for NBS. Therefore, the MRE11A gene was sequenced in both patients and 
found to be compound heterozygous for three different types of mutations: an A-to-C 
transversion in nucleotide 658 (c.658A>C), a G-to-A transition in nucleotide 16513 (g.16513; 
i.e. c.659+1G>A) and an A-to-G transition in position 338 (c.338A>G). Patient-1 had 
c.658A>C substitution plus a g.16513 splicing mutation, and patient-2 had c.658A>C and 
c.338A>G substitutions. Sequencing analysis demonstrated that g.16513G>A resulted in 
exon 7 skipping leading to a premature termination codon (p.Ser183ValfsX31). The 
c.658A>C substitution located within exon 7 did not alter amino acids but affected splicing 
efficiency that contributed to exon 7 skipping. The c.338A>G situated in exon 5 lead to a 
missense mutation with an amino acid substitution of Asp to Gly at  residue 113 (D113G) 
located within the highly conserved phosphoesterase domain, which is essential for 
endonuclease activity. The c.658A>C substitution common to both patients and the 
c.338A>G substitution resulted in a reduced level of normally functioning Mre11 protein.  
The 15 Saudi Arabian patients were related to 5 independent families and represent the 
largest ATLD cohort (Fernet et al., 2005;  Khan et al., 2008;  Bohlega et al., 2011). Genetic 
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Fig. 3. Representation of the human (a) MRE11A gene, (b) cDNA and (c) protein. Location of 
the exonic (cDNA) and intronic mutations causing the 25 confirmed cases of ATLD from 
United Kingdom (UK), Italy (ITA), Japan (JPN) and the Kingdom of Saudi Arabia (KSA), are 
indicated. Only mutations detectable in a full-length Mre11 protein are indicated at the 
protein level. (Assembled from www.ensembl.org and Taylor et al., 2004 with substantial 
modifications and update). 
studies have identified in all patients the same G to C transversion at position 630 
(c.630G>C) located in exon 7, which results in the missense change of Trp to Cys (W210C). 
No other nucleotide change was identified in the coding sequences or flanking intronic 
sequences of MRE11A. Tryptophan at position 210 is a highly conserved residue in the 
Mre11 protein, being invariable from yeast to mammals and its replacement by the small 
polar residue cysteine is likely to affect the structure or function of the protein. In addition, 
this residue lies between motifs III and IV of the N-terminal nuclease domain of the Mre11 
protein, a region where another missense mutation (N117S) had been identified in ATLD 
patients (Figure 3). Thus, all patients were homozygous for a novel missense mutation (c.630 
G>C) of the MRE11A gene that seems to be specific to Saudi Arabia. The resulting amino 
acid change (W210C) does not seem to affect the level of Mre11 protein expression but 
results in an inability of the mutant Mre11 protein to interact with Nbs1 protein leading to 
destabilization of the MRN complex and the loss of its normal function.   
4. Frequency of MRE11A gene mutations 
While the frequency of the different mutations in the MRE11A gene is unknown, the high 
number of Saudi ATLD patients with the 630 G>C particular mutation would suggest 
noticeable frequency of heterozygous carriers in the Arabic peninsula. This may have 
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impact on premarital and preimplantation screening to limit genetic diseases and to provide 
informed genetic counseling. Therefore, a study was initiated to assess the allelic frequency 
of this mutation (Alsbeih et al., 2008). Currently, a cohort of 528 phenotypically normal 
individuals was included in the study. There were 146 females and 382 males. The 
methodological procedures to detect the G to C missense mutation at nucleotide 630 of the 
MRE11A gene and the PCR primers used were described previously (Alsbeih et al., 2008). 
Briefly, genomic DNA was extracted from 3-5 ml peripheral whole blood or cultured skin 
fibroblasts, using Puregene DNA Purification Kit (Gentra System, Minneapolis, MN). 
Relevant segments of DNA were amplified by thermal cycling (95 °C for 15 min, 39 rounds 
of 95 °C for 1 min, 55 °C for 1 min and 72 °C for 1 min and final extension at 72 °C for 7 min) 
using HotStarTaq DNA polymerase (Qiagen, Venlo, Netherlands), and 50 ng template DNA 
in 25 microlitter volume with standard reaction conditions. The quality of the PCR product 
was checked by running 5 microlitter of the reaction in 1% agarose gel. The amplified 
fragment was directly sequenced using the DYEnamic ET Dye Terminator Cycle Sequencing 
Kit (Amersham Biosciences, Piscatway, NJ) according to the manufacturer’s instruction, and 
were run on the MegaBase 1000 sequencer (Applied Biosystems, Fostercity, CA). Sequencing 
results were aligned to the corresponding reference sequence and the missense mutation 
was genotyped using SeqManII sequence analysis software (DNASTAR Inc., Madison, WI).  
Out of the 528 individuals, only two were heterozygous (G630C) for the missense mutation, 
while the remaining 526 were all wild-type. The genotype and allelic distributions of the 
missence mutation in the MRE11A are listed in Table 1. This gives a frequency of 99.6 for the 
G/G wild-type and 0.4% for the heterozygous G/C. In addition, one individual was 
heterozygous for a new SNP in intron 6, position 18026 (Ensembl annotation), 131 
nucleotides upstream of the G630C mutation (Alsbeih et al., 2008). 
 
Genotype 
and allele 
Individuals n Frequencies (%) 
   
MRE11A g.18157 mutation G>C 
G/G 526 99.6 
G/C 2 0.4 
C/C 0 0 
G 1054 99.8 
C 2 0.2 
   
Table 1. Genotype and allele frequencies of the MRE11A 630G>C (g.18157, p.210 Trp>Cys) 
misense mutation in 528 Saudi individuals. Sequence reported on the negative strand as per 
the gene direction. 
The presence of two heterozygous individuals indicates the existence of this rare mutation 
in the population with an estimated heterozygous genotype G/C of 0.4% and estimated 
mutant C allele frequency of 0.2%. Therefore, the diagnosis of MRE11A ATLD should be in 
the mind of physicians whenever they encounter an A-T like disorder and genetic study 
should be carried out to confirm the diagnosis. This is how the 5 patients reported by 
Bohlega and colleagues were diagnosed (Bohlega et al., 2011). The fact that the 10 previously 
described Saudi ATLD patients (Fernet et al., 2005) are from the central region of Saudi 
Arabia could suggest higher frequency of this mutation in geographically isolated families 
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with high level of consanguineous marriages. However, larger studies with members from 
different regions are required to precisely estimate the exact frequency of this mutation in 
Saudi Arabia.  
5. ATLD and other ataxia causing disorders 
Ataxia occurs when parts of the nervous system that control movement are damaged. Most 
disorders that result in ataxia cause cells in the cerebellum, and sometimes in the spine or 
even the peripheral nervous systems, to degenerate or atrophy. Cerebellar and 
spinocerebellar degeneration have many different causes. Genetic causes form a 
heterogeneous group with different pattern of inheritance and onset of the symptoms. 
Currently this group encompasses the following distinct conditions: ataxia telangiectasia (A-
T), ataxia telangiectasia-like disorder (ATLD), ataxia oculomotor apraxias (AOA), and the 
two "A-T variants", Nijmegen breakage syndrome (NBS) with microcephaly but without 
ataxia, and A-T (Fresno) that combines features of both NBS and A-T. This is in addition to 
other hereditary ataxia such as Friedreich ataxia (FA) and Machado-Joseph Disease (MJD) 
caused by triplet repeat expansion, spastic ataxia of the Charlevoix-Saguenay, Autosomal 
recessive ataxia associated with isolated vitamin E deficiency, Infantile onset spinocerebellar 
ataxia, ataxia with hearing loss and optic atrophy, spinocerebellar ataxia with axonal 
neuropathy, Cayman ataxia, cerebellar ataxia with mental retardation optic atrophy and 
skin abnormalities, Salla syndrome, Marinesco-Sjögren and the childhood spinocerebellar 
ataxia (Bouhlal et al., 2005). Table 2 summarizes some of the genetic disorders grouped 
under hereditary ataxias and its variants of relevance to ATLD. 
 
Disorder Acronym Inheritance Chromosomal 
location 
Protein 
affected 
Reference 
Ataxia 
telangiectasia 
A-T Recessive 11q22-23 ATM (Savitsky et 
al., 1995) 
Ataxia 
telangiectasia-like 
disorder 
ATLD Recessive 11q21 Mre11 (Stewart et al., 
1999) 
Ataxia oculomotor 
apraxia 1 
AOA1 Recessive 9p13 Aprataxin (Date et al., 
2001) 
Ataxia oculomotor 
apraxia 2 
 
AOA2 Recessive 9q34 Senataxin (Moreira et 
al., 2004) 
Nijmegen breakage 
syndrome 
NBS Recessive 8q21 Nbs1 
(nibrin) 
(Varon et al., 
1998) 
Ataxia 
telangiectasia 
Fresno* 
A-T Fresno Recessive 11q23 ATM (Gilad et al., 
1998) 
Friedreich ataxia FRDA Recessive 9q13-q21 Frataxin (Campuzano 
et al., 1996) 
Machado-Joseph 
Disease 
MJD Dominant 14q32 Ataxin-3 (Kawaguchi et 
al., 1994) 
* A-T Fresno combines features of A-T and NBS with mutation in ATM. 
Table 2. Genetic disorders grouped under hereditary ataxias and its variants 
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Diagnosis is usually suggested by the clinical manifestations. Non-specific complementary 
tests may be done to differentiate between them or to exclude other disorders or conditions 
that may cause ataxia. The molecular characterization of these different disorders allows 
genetic tests to confirm a clinically suggested diagnosis. In general, there are no specific 
treatments available for most of the inherited ataxia disorders. Symptoms are treated with 
physical and occupational therapy, assistive devices, and medication for muscle pain or 
spasms that may occur. Genetic counseling provides education to parents of individuals 
with an inherited ataxia disorder to be aware that they may pass the disorder on to their 
children. Some affected families may choose to test members to see if they have inherited 
the gene responsible for the disorder. 
6. Conclusions 
Hereditary ataxias are a heterogeneous group of cerebellar degeneration causing failure of 
muscle control, resulting in a lack of coordination, imbalance and ataxic gait. ATLD is a rare 
variant of A-T with only 25 confirmed cases worldwide, 4 in the UK, 2 in Italy, 4 in Japan 
and 15 in Saudi Arabia. The patients were either homozygous or compound heterozygous 
for 10 different hypomorphic mutations in exons and splice sites. The 15 Saudi Arabian 
patients were related to 5 independent families and represent the largest ATLD cohort 
which would suggest the presence of a noticeable frequency of heterozygous carriers of 
MRE11A gene mutation in the population. Therefore, the diagnosis of ATLD should be in 
the mind of physicians whenever they encounter an A-T like disorder and genetic study 
should be carried out to confirm the diagnosis. Testing for MRE11A gene mutations could 
ultimately be incorporated to premarital, pre-implementation or prenatal screening to 
reduce the risk of transmission of genetic diseases.  
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